A molecular description of ligand binding to the two overlapping binding pockets of the nuclear vitamin D receptor (VDR): structure-function implications.
Molecular modeling results indicate that the VDR contains two overlapping ligand binding pockets (LBP). Differential ligand stability and fractional occupancy of the two LBP has been physiochemically linked to the regulation of VDR-dependent genomic and non-genomic cellular responses. The purpose of this report is to develop an unbiased molecular modeling protocol that serves as a good starting point in simulating the dynamic interaction between 1alpha,25(OH)2-vitamin D3 (1,25D3) and the VDR LBP. To accomplish this goal, the flexible docking protocol developed allowed for flexibility in the VDR ligand and the VDR atoms that form the surfaces of the VDR LBP. This approach blindly replicated the 1,25D3 conformation and side-chain dynamics observed in the VDR X-ray structure. The results are also consistent with the previously published tenants of the vitamin D sterol (VDS)-VDR conformational ensemble model. Furthermore, we used flexible docking in combination with whole-cell patch-clamp electrophysiology and steroid competition assays to demonstrate that (a) new non-vitamin D VDR ligands show a different pocket selectivity when compared to 1,25D3 that is qualitatively consistent with their ability to stimulate chloride channels and (b) a new route of ligand binding provides a novel hypothesis describing the structural nuances that underlie hypercalceamia.
Mizwicki
Mathew T
MT
Department of Biochemistry, University of California, 5470 Boyce Hall, Riverside, CA 92521, USA. Mathew.mizwicki@ucr.edu
Menegaz
Danusa
D
Yaghmaei
Sepideh
S
Henry
Helen L
HL
Norman
Anthony W
AW
D018360:Crystallography, X-Ray / Q000379:methods; D004594:Electrophysiology / Q000379:methods; D018922:HL-60 Cells; D006801:Humans; D006934:Hypercalcemia / Q000378:metabolism / Q000473:pathology; D008024:Ligands; D008297:Male; D008958:Models, Molecular; D008968:Molecular Conformation; D018408:Patch-Clamp Techniques; D011485:Protein Binding; D018167:Receptors, Calcitriol / Q000378:metabolism*; D012708:Sertoli Cells / Q000378:metabolism; D013329:Structure-Activity Relationship; D013816:Thermodynamics
D008024:Ligands; D018167:Receptors, Calcitriol
Nat Rev Drug Discov. 2004 Jan;3(1):27-41
14708019
J Biol Chem. 1975 Nov 10;250(21):8382-8
172496
Proc Natl Acad Sci U S A. 2004 May 4;101(18):6900-4
15118084
Biochem Biophys Res Commun. 1994 May 30;201(1):394-401
8198601
Proc Natl Acad Sci U S A. 2001 May 8;98(10):5491-6
11344298
J Steroid Biochem Mol Biol. 2005 Oct;97(1-2):69-82
16055325
Biochem Biophys Res Commun. 1975 Jul 8;65(1):24-30
167766
Biochem Biophys Res Commun. 1974 Sep 9;60(1):179-85
4371082
Endocr Rev. 1995 Apr;16(2):200-57
7781594
Sci Signal. 2009 Jun 16;2(75):re4
19531804
J Med Chem. 1998 Apr 23;41(9):1467-75
9554880
Proc Natl Acad Sci U S A. 2004 Aug 31;101(35):12876-81
15326291
J Am Chem Soc. 1975 Aug 20;97(17):4980-5
170323
J Alzheimers Dis. 2009;17(3):703-17
19433889
J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):243-62
17368177
J Steroid Biochem Mol Biol. 1999 Dec 15;71(3-4):111-21
10659699
Mol Cell. 2000 Jan;5(1):173-9
10678179
J Bone Miner Res. 2005 Mar;20(3):447-54
15746989
Steroids. 2005 May-Jun;70(5-7):464-71
15862832
J Inflamm (Lond). 2009 May 13;6:15
19439083
J Steroid Biochem. 1984 Feb;20(2):611-5
6323873
J Biol Chem. 2009 Dec 25;284(52):36292-36301
19801650
Endocrinology. 2001 Jan;142(1):59-67
11145567
J Exp Med. 1999 Dec 6;190(11):1583-94
10587349
J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):389-95
17223545